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Free ricin A-chain was actively taken up in vitro by rat liver non-parenchymal cells but not by parenchymal 
cells. A-chain uptake by non-parenchymal cells could be selectively inhibited by D-mannose, L-fucose or 
ovalbumin and was markedly decreased after partial removal of mannose residues from the oligosaccharides 
present in the glycoprotein by enzymic deglycosylation. Uptake of free ricin B-chain by non-parenchymal 
cells was greater than that by parenchymal cells but in both cases was little influenced by enzymic deglycosyl- 
ation of the glycoprotein. The results are consistent with mannose receptor recognition of ricin A-chain 
by non-parenchymal cells and have important implications for the clinical use in vivo of antibody-ricin 
A-chain conjugates in cancer therapy. 
Ricin Deglycosylation Mannose oligosaccharide (Liver cell) 
1. INTRODUCTION 
Ricin is a glycoprotein (Mr 62000) from castor 
beans (Ricinus communis) which consists of two 
similar-sized polypeptide subunits (A- and B- 
chains) linked by a disulphide bond and is a potent 
inhibitor of protein synthesis in eukaryotic cells. 
The B-chain is generally regarded as necessary for 
the binding of ricin to cells which is followed by 
transfer of the A-chain to the cytosol where it inac- 
tivates the 60 S ribosomal subunits (review [l]). 
Pharmacokinetic studies on ricin have shown 
that the glycoprotein is rapidly removed from the 
blood by the reticuloendothelial cells (RES), 
especially by the liver [2] in which severe damage 
Abbreviations: GlcNac, N-acetyl-D-glucosamine; Xyl, 
D-xylose; Man, D-mannose; Fuc, L-fucose, PMSF, 
phenylmethylsulphonyl fluoride; PBS, phosphate- 
buffered saline (137 mM NaCl, 2.7 mM KCl, 8.1 mM 
NazHPOd, 1.5 mM KHzPOd, pH 7.3) 
occurs to the hepatic sinusoids [3] as a result of ac- 
tive uptake by the non-parenchymal cell popula- 
tion [4]. We have established previously that liver 
non-parenchymal cells in vitro accumulate native 
ricin by a dual recognition process. The toxin 
predominantly binds to these cells, as with other 
cell types, through recognition of galactose- 
containing glycoproteins and glycolipids on the cell 
surface, but it is the selective interaction of cellular 
mannose receptors with the mannose-containing 
oligosaccharides in the toxin that predominantly 
stimulates endocytosis [5]. 
Both the A- and B-chains of ricin contain car- 
bohydrate structures that potentially could be 
recognised by the RES, although not all of the 
oligosaccharides may be exposed in the intact tox- 
in. The A-chain comprises 64% of an Al compo- 
nent (Mr 30000) which contains a single car- 
bohydrate unit of composition (Man)j-q- 
(Fu~)~(Xyl)r(GlcNAc)~ and 34% of a heavier AZ 
component (Mr 32000) which contains an addi- 
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tional second mannose-rich oligosaccharide [6]. 
The B-chain (Mr approx. 30000) contains two 
oligomannose saccharides of composition 
(Man).+e(GlcNAc)z [6,7]. Involvement of the B- 
chain carbohydrate in the selective uptake of ricin 
by hepatic non-parenchymal cells might be ex- 
pected from our earlier studies [4,5] but this has 
not yet been fully established. Furthermore, it is 
not known if free ricin A-chain can be taken up by 
the RES through recognition of its own oligosac- 
charide side chains. Here we have examined the 
uptake in vitro by different liver cell types of free 
ricin A-chain and free ricin B-chain both before 
and after modification of their carbohydrate by 
enzymic deglycosylation. The results show that 
hepatic non-parenchymal cells actively accumulate 
free ricin A- and B-chains and demonstrate the im- 
portance of the mannose-containing oligosac- 
charides present in both chains to the recognition 
and selective uptake of the glycoproteins by these 
cells. 
2. MATERIALS AND METHODS 
Extensive details of preparation of the various 
ricin components used in the present study have 
been published elsewhere [6] but the procedures 
are briefly described. 
2.1. Preparation of ricin A- and B-chains 
Ricin (electrofocusing at pH 7.2) was purified 
from an aqueous extract of untoasted castor bean 
cake, essentially as described by Nicolson and 
Blaustein [8]. Ricin was split into its constituent 
chains by reduction with 2-mercaptoethanol 
followed by ion-exchange chromatography on 
DEAE-Sepharose (Pharmacia). Contaminating 
ricin was removed from the A-chain by two 
passages through asialofetuin-Sepharose and from 
the B-chain by ion-exchange chromatography on 
Cm-Sepharose (Pharmacia) as described [a]. 
2.2 Deglycosylation of A- and B-chains 
A-chain was treated with a-mannosidase 
(Sigma) as follows. A-chain (3 ml at 0.685 mg/ml 
in 0.2 M sodium citrate buffer, pH 5.5) was treated 
with 0.75 U cy-mannosidase in the presence of 1 
mM PMSF for 2 days at room temperature. 
Deglycosylation resulted in a decrease in M, of the 
Al-chain component by 600 and the AZ-chain com- 
ponent by 2000 as assessed by polyacrylamide gel 
electrophoresis [6]. All A-chain preparations pro- 
duced comparable inhibition of protein synthesis 
in the reticulocyte lysate assay [9]. Deglycosylation 
of the B-chain was carried out by treatment at 
room temperature of isolated B-chain (2 mg/ml) in 
0.1 M citrate buffer, pH 5.5, containing 0.2 M D- 
galactose, 0.25% 2-mercaptoethanol and 1 mM 
PMSF (Sigma), either with only a-mannosidase 
(0.5 U/ml) for 3 days, or with endoglycosidase H
(Miles Labs, 10 mu/ml) for 2 days, followed by 
addition of cu-mannosidase (0.18 U/ml) for a fur- 
ther 24 h. After deglycosylation 2 mg B-chain was 
filtered at a flow rate of 0.5 ml/min through 1.5 ml 
of a Con A-Sepharose column equilibrated with 
PBS containing 0.1 M galactose to remove 
undegraded B-chain. After treatment with (Y- 
mannosidase the B-chain showed an increase in 
mobility when analysed by polyacrylamide gel elec- 
trophoresis equivalent o a decrease in M, of 1500 
[6]. However, approx. 50% of the material could 
still be bound by Con A-Sepharose indicating an 
incomplete removal of mannose residues. Previous 
studies had shown that treatment of the B-chain 
with endoglycosidase H alone caused a decrease in 
M, of 1200 consistent with removal of only one of 
the oligosaccharide chains, the other probably be- 
ing protected by the polypeptide structure [6]. Se- 
quential treatment of the B-chain with endo- 
glycosidase H and a-mannosidase resulted in a fur- 
ther increase in its electrophoretic mobility 
(equivalent to a reduction in M, of approx. 400) 
associated with removal of additional mannose 
residues from the endoglycosidase H-resistant 
oligosaccharide [6], although 25% of the material 
still retained its ability to bind to Con A- 
Sepharose. 
2.3. Uptake of toxins by liver cells in vitro 
Liver cells were isolated from adult male Wistar 
rats (LACP) by collagenase liver perfusion as 
detailed previously, using Sigma type I or Boeh- 
ringer collagenase to isolate non-parenchymal and 
parenchymal cells, respectively [5]. Uptake of tox- 
ins (0.1 pg/ml) labelled with Nalz51 (Amersham 
IMS30) was measured in primary monolayer 
cultures incubated for 20 min at 37’C in serum- 
free medium (GMEM, Gibco-Europe) sup- 
plemented with 1 mM glutamine (Gibco) and 50 
pg/ml gentamycin (Flow). Added sugars and 
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ovalbumin were obtained from Sigma. Cells were 
harvested and their toxin content which comprised 
both bound and internalized components was 
measured as in [5]. 
3. RESULTS 
3.1. Uptake of ricin A-chain by liver cells in vitro 
Free ricin A-chain was actively taken up by 
hepatic non-parenchymal cells in vitro and the up- 
take specifically inhibited (75-90%) by the 
presence of the simple sugars D-mannose and L- 
fucose or the mannose-terminated glycoprotein 
ovalbumin, but not by D-galactose (table 1). The 
carbohydrate in ricin A-chain is known not to be 
susceptible to removal by endoglycosidases but 
susceptible to removal by cu-mannosidase [6]. After 
treatment of the free A-chain with a-mannosidase 
a 60% fall in uptake of the toxin by non- 
parenchymal cells in vitro was observed which was 
associated also with a marked loss of inhibition by 
D-mannose or L-fucose (table 1). This residual 
degree of inhibition was similar to that observed in 
the presence of D-xylose (20-25(rlo) or other irrele- 
vant sugars (not shown) and known from previous 
studies to be due to a non-specific cytostatic inhibi- 
tion of uptake, probably caused by exposure of the 
cells to relatively high concentrations of sugars [5]. 
The results are therefore consistent with mannose 
receptor-mediated uptake of ricin A-chain by 
hepatic non-parenchymal cells. However, oval- 
bumin unexpectedly caused a similar level of in- 
hibition in the uptake of both native A-chain and 
the a-mannosidase-treated material, which may 
reflect a fortuitous steric inhibition by the cell- 
bound ovalbumin of an uptake mechanism not in- 
volving the cellular mannose receptors. This con- 
clusion was supported by the observation that up- 
take of both the native A-chain and w 
mannosidase-treated toxin was also inhibited in the 
presence of lactoferrin, a glycoprotein containing 
peripheral L-fucose (not shown). Parenchymal 
cells showed only a very limited non-specific up- 
take of ricin A-chain (0.55-0.75 ng/106 cells) 
which was essentially unaffected by enzyme 
modification of the toxin or the presence of simple 
hexose sugars. 
3.2. Uptake of ricin B-chain by liver ceils in vitro 
Ricin B-chain uptake by non-parenchymal cells 
was approximately twice that observed for ricin A- 
chain, but in contrast enzyme modification of the 
B-chain with cY-mannosidase only slightly lowered 
the level of uptake (table 2). Accumulation of both 
untreated B-chain and the cu-mannosidase-treated 
material, however, was most strongly inhibited 
(65-70%) by D-mannose, L-fucose or ovalbumin; 
the inhibitory effect of D-galactose being lower 
(approx. 40%). These results show that only par- 
tial removal of mannose residues from the B-chain 
by a-mannosidase [6] was insufficient to alter its 
recognition and uptake by non-parenchymal cells. 
Accordingly, it might have been expected that 
treatment of the B-chain with endoglycosidase H 
and cu-mannosidase would have been more effec- 
tive at lowering its uptake by non-parenchymal 
cells. However, only a 15% decrease in B-chain up- 
take was observed although inhibition by D- 
mannose and L-fucose was significantly decreased 
whilst the inhibition produced by D-galactose was 
Table 1 
Uptake of ricin A-chain by rat liver non-parenchymal cells in vitro 
A-chain Uptake 
(ng/106 cells) 
% inhibition of uptake in the presence of 
D-Mannose L-Fucose D-Galactose D-Xylose Ovalbumin 
(100 mM) (100 mM) (100 mM) (100 mM) (1 mg/ml) 
Free A-chain 7.6 f 1.7 81 75 20 25 90 
a-Mannosidase-treated 
A-chain 3.3 + 1.2 35 29 24 20 81 
Toxin uptake was measured in monolayer cultures of 2 x lo6 non-parenchymal cells which were incubated for 20 min 
at 37°C in 3 ml serum-free culture medium containing 0.1 ag/ml ‘251-labelled toxin in the presence and absence of the 
additions indicated. Uptake values are quoted as means f SD for 5 separate determinations. Details of the preparation 
and characteristics of the toxins used are given in section 2 
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Table 2 
Uptake of ricin B-chain by rat liver parenchymal and non-parenchymal cells in vitro 
Cell type B-chain Uptake 
(ng/ lo6 cells) 
% inhibition of uptake in the presence of 
D-Mannose L-Fucose D-Galactose D-Xylose Ovalbumin 
(100 mM) (100 mM) (100 mM) (1~mM) (1 mg/ml) 
Non-paren- free B-chain 











16.8 f 4.5 67 50 41 22 64 
15.1 z!z 5.1 69 57 42 23 65 
14.2 i 4.0 39 38 55 24 32 
3.1 + 0.4 28 22 74 19 13 
3.3 Lt 0.7 20 23 79 23 15 
3.9 f 0.8 17 23 80 24 13 
Monolayer cultures of 1.5 x lo6 parench~al and 2.0 x lo6 non-paren~hymal cells were used. Other details are given 
in table 1 and the preparation and characteristics of the B-chain are described in section 2 
marginally increased (table 2). Analysis of the B- 
chain after the double enzyme treatment had in- 
dicated that although this gave rise to the greatest 
level of deglycosylation that could be obtained in 
undenatured B-chain [6] it was still incomplete 
with a proportion of the material retaining its abili- 
ty to bind to Con A-Sepharose (cf. section 2.2). 
This suggests that elimination of mannose- 
dependent uptake of ricin B-chain by non- 
parench~~ cells requires complete removal of 
both oligosaccharides from the polypeptide, Up- 
take of ricin B-chain by parenchymal cells was 
5-7-times that measured for the A-chain but 
similar for both native and enzyme-treated 
materials and only D-galactose showed any 
marked inhibition of B-chain uptake. Taken 
together these results are consistent with an in- 
teraction of the B-chain with only galactosyl- 
binding sites in paren~h~al cells and both 
galactosyl-binding sites and mannose receptors in 
non-parenchymal cells. 
4. DISCUSSION 
The most important finding of this study is that 
free ricin A-chain can be actively taken up by 
hepatic non-parenchymal cells but that it is not ex- 
tensively accumulated by parenchymal cells. The 
results are consistent with the accumulation of 
ricin A-chain through recognition of its mannose 
oligosaccharides by the mannose receptors known 
to be present in non-parenchymal cells [lo] and 
which we have shown previously to be involved in 
the uptake of native ricin [4,5]. These findings 
have considerable implications for the clinical use 
in vivo of antibody-ricin A-chain conjugates in 
cancer therapy [lo-121 and support the current 
view 1121 that significant removal from the blood 
of these types of immunotoxins may occur as a 
result of recognition of the mannose oligosac- 
charides in the ricin A-chain component by hepatic 
sinusoidal or other reticul~ndotheli~ cells, thus 
severely diminishing their antineoplastic potential. 
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